Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of Ad5-EBOV Ebola vaccine
PACTR201509001259869Phase 2Not yet recruiting
- Sponsor
- Sierra Leone Ministry of Health and Sanitation
- Start
- Oct 2015
- Modality
- Vaccines & Immunotherapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 1
01
Overview
Phase 2, single-arm trial of Ad5-EBOV in Ebola virus disease (EVD), sponsored by Sierra Leone Ministry of Health and Sanitation. Planned start Oct 2015; status: not yet recruiting.
02
Drugs
Ad5-EBOV
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201509001259869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201509001259869.